Maine cancels low-cost Canadian drug program

Sunday September 9, 2012 5:15 PM

AUGUSTA, Maine (AP) — Maine officials' ruling that CanaRx, a Canadian firm that distributes prescription medications by mail, cannot be licensed in Maine will affect 1,200 Maine households using the company's services.

The Bangor Daily News (bit.ly/NgREjj) says Attorney General William Schneider's decision imperils more than $3 million in annual savings budgeted for the state employees' health plan.

CanaRx senior program adviser Chris Collins says the decision affects about 1,200 Maine households and also poses financial repercussions for the city of Portland and Guilford-based Hardwood Products Co., both of which have contracted with CanaRx for years.

CanaRx offers reduced prices to plan providers and does not charge co-payments to participants, creating significant savings for both.

.

___

Information from: Bangor Daily News, http://www.bangordailynews.com

©2013 by The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Currently in Columbus
66°
Overcast

Today

Full schedule
8:00
The Big Bang Theory
8:30
Two and a Half Men
9:00
Person Of Interest
10:00
Elementary
11:00
10TV News @ 11PM
11:35
Late Show with David Letterman